<DOC>
	<DOCNO>NCT01746602</DOCNO>
	<brief_summary>Long term treatment anti-glaucomatous drug show increase incidence dry eye syndrome know consequence ocular discomfort epithelial keratitis . Given thin tear film appear risk factor development aggravation dry eye syndrome , current study seek investigate whether tear film thickness change topical treatment anti-glaucomatous drug healthy subject . For purpose , tear film thickness measure baseline single instillation one 5 study drug one randomly choose eye . In addition , one group 20 subject receive drug serve second control . Drug effect tear film thickness compare fellow , non-treated eye . In addition , effect tear film thickness timolol preservative ( Timoptic 0.5 % ) compare timolol without preservative ( Timophtal sine 0.5 % ) three lubricant different viscosity ( Genteal HA , Hylo-Comod , Thealoz ) .</brief_summary>
	<brief_title>Effect Topical Glaucoma Therapy Tear Film Stability Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<criteria>Men woman age 18 year Normal finding medical history physical examination unless investigator considers abnormality clinically irrelevant Normal ophthalmic finding , ametropia &lt; 6 Dpt . Regular use medication ( except contraceptive ) , abuse alcoholic beverage , participation clinical trial 3 week precede study Treatment previous 3 week drug Symptoms clinically relevant illness 3 week first study day Patients know hypersensitivity study drug ingredient History current COPD asthma AVblock grade II Ametropy â‰¥ 6 Dpt Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>topical lubricant</keyword>
	<keyword>tear film thickness</keyword>
	<keyword>anti-glaucoma drug</keyword>
	<keyword>break time</keyword>
	<keyword>anti-glaucoma treatment</keyword>
</DOC>